Literature DB >> 9667605

Genetic characteristics of myoadenylate deaminase deficiency.

H T Verzijl1, B G van Engelen, J A Luyten, G C Steenbergen, L P van den Heuvel, H J ter Laak, G W Padberg, R A Wevers.   

Abstract

Two types of myoadenylate deaminase (MAD) deficiency have been described, primary or inherited, and secondary or acquired MAD deficiency. In this study, we investigated whether secondary MAD deficiency is indeed acquired or merely coincidental. We demonstrated the same underlying molecular defect, a C34T transition, in both types of deficiency. Furthermore, the same frequency of the mutant MAD allele was found in the general population as in patients with neuromuscular complaints. We therefore conclude that in the Dutch population, secondary MAD deficiency is merely a "coincidental" finding, and that MAD deficiency is a harmless genetic variant.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667605     DOI: 10.1002/ana.410440124

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

1.  The effect of AMPD1 genotype on blood flow response to sprint exercise.

Authors:  Barbara Norman; Anders T Nygren; Jacek Nowak; Richard L Sabina
Journal:  Eur J Appl Physiol       Date:  2008-01-26       Impact factor: 3.078

2.  Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.

Authors:  M A Tarnopolsky; G Parise; M J Gibala; T E Graham; J W Rush
Journal:  J Physiol       Date:  2001-06-15       Impact factor: 5.182

3.  Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity.

Authors:  Antonietta R M Sabbatini; Antonio Toscano; Mohammed Aguennouz; Daniela Martini; Enza Polizzi; Maria Ranieri-Raggi; Arthur J G Moir; Alba Migliorato; Olimpia Musumeci; Giuseppe Vita; Antonio Raggi
Journal:  J Muscle Res Cell Motil       Date:  2006-03-29       Impact factor: 2.698

Review 4.  [Rhabdomyolysis and myoglobinuria].

Authors:  A Lindner; S Zierz
Journal:  Nervenarzt       Date:  2003-05-14       Impact factor: 1.214

5.  Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent.

Authors:  Samya Chakravorty; Babi Ramesh Reddy Nallamilli; Satish Vasant Khadilkar; Madhu Bala Singla; Ashish Bhutada; Rashna Dastur; Pradnya Satish Gaitonde; Laura E Rufibach; Logan Gloster; Madhuri Hegde
Journal:  Front Neurol       Date:  2020-11-05       Impact factor: 4.086

6.  AMP deaminase deficiency in skeletal muscle is unlikely to be of clinical relevance.

Authors:  Frank Hanisch; Pushpa Joshi; Stephan Zierz
Journal:  J Neurol       Date:  2008-03-14       Impact factor: 4.849

7.  Interaction among Skeletal Muscle Metabolic Energy Systems during Intense Exercise.

Authors:  Julien S Baker; Marie Clare McCormick; Robert A Robergs
Journal:  J Nutr Metab       Date:  2010-12-06

8.  Diagnostic Algorithm for Glycogenoses and Myoadenylate Deaminase Deficiency Based on Exercise Testing Parameters: A Prospective Study.

Authors:  Fabrice Rannou; Arnaud Uguen; Virginie Scotet; Cédric Le Maréchal; Odile Rigal; Pascale Marcorelles; Eric Gobin; Jean-Luc Carré; Fabien Zagnoli; Marie-Agnès Giroux-Metges
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

9.  Association of Mitochondrial Dysfunction and Fatigue: A Review of the Literature.

Authors:  Kristin Filler; Debra Lyon; James Bennett; Nancy McCain; Ronald Elswick; Nada Lukkahatai; Leorey N Saligan
Journal:  BBA Clin       Date:  2014-06-01

Review 10.  Role of the HPRG Component of Striated Muscle AMP Deaminase in the Stability and Cellular Behaviour of the Enzyme.

Authors:  Francesca Ronca; Antonio Raggi
Journal:  Biomolecules       Date:  2018-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.